Related Experiment Videos
Rat liver arginase suppresses mixed lymphocyte reaction
1Experimental Surgery, National Children's Hospital Medical Research Center, Tokyo.
Journal of Biochemistry
|March 1, 1990
Summary
Researchers identified a liver arginase as a key inhibitor of the mixed lymphocyte reaction (MLR). This finding suggests that liver factors may play a role in controlling immune responses.
Area of Science:
- Immunology
- Biochemistry
- Enzymology
Background:
- The mixed lymphocyte reaction (MLR) is a key immunological assay used to study T-cell mediated immune responses.
- An inhibitory factor influencing MLR was previously detected in rat liver homogenate.
Purpose of the Study:
- To purify and characterize the inhibitory factor of MLR from rat liver homogenate.
- To elucidate the identity and mechanism of action of the MLR inhibitor.
Main Methods:
- Purification of the inhibitor using chloroform treatment, ammonium sulfate precipitation, ion-exchange chromatography, and gel filtration.
- Molecular weight determination by SDS-PAGE.
- N-terminal amino acid sequencing.
- Enzyme activity assays for arginase.
- Cell culture experiments to assess L-arginine depletion and immune cell proliferation.
Main Results:
- A 34,000 molecular weight inhibitor was purified.
- The N-terminal amino acid sequence showed high homology to rat arginase.
- The purified inhibitor exhibited significant arginase activity.
- Inhibition of MLR was linked to L-arginine depletion in the culture medium.
- Restoring L-arginine levels recovered T-cell proliferation.
Conclusions:
- The purified MLR inhibitor is identified as rat liver arginase.
- Liver arginase inhibits MLR by depleting L-arginine.
- This study highlights a potential role for liver-derived factors in modulating immune responses.